221 related articles for article (PubMed ID: 15544331)
1. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
Datta-Mannan A; Stone MJ
Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
[TBL] [Abstract][Full Text] [Related]
2. Specificity determinants for chemokine recognition identified using eotaxin-MCP-1 chimeras.
Mayer MR; Parody TR; Datta-Mannan A; Stone MJ
FEBS Lett; 2004 Jul; 571(1-3):166-70. PubMed ID: 15280036
[TBL] [Abstract][Full Text] [Related]
3. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
4. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
Duchesnes CE; Murphy PM; Williams TJ; Pease JE
Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
[TBL] [Abstract][Full Text] [Related]
5. Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
Mayer KL; Stone MJ
Proteins; 2003 Feb; 50(2):184-91. PubMed ID: 12486712
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
7. Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold.
Datta A; Stone MJ
Protein Sci; 2003 Nov; 12(11):2482-91. PubMed ID: 14573861
[TBL] [Abstract][Full Text] [Related]
8. Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.
Crump MP; Spyracopoulos L; Lavigne P; Kim KS; Clark-lewis I; Sykes BD
Protein Sci; 1999 Oct; 8(10):2041-54. PubMed ID: 10548050
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.
Frade JM; Llorente M; Mellado M; Alcamí J; Gutiérrez-Ramos JC; Zaballos A; Real G; Martínez-A C
J Clin Invest; 1997 Aug; 100(3):497-502. PubMed ID: 9239395
[TBL] [Abstract][Full Text] [Related]
10. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
[TBL] [Abstract][Full Text] [Related]
12. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
13. Eotaxin and monocyte chemotactic protein-3 use different modes of action.
Chung IY; Kim YH; Choi MK; Noh YJ; Park CS; Kwon DY; Lee DY; Lee YS; Chang HS; Kim KS
Biochem Biophys Res Commun; 2004 Feb; 314(2):646-53. PubMed ID: 14733956
[TBL] [Abstract][Full Text] [Related]
14. A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2.
Izhak L; Wildbaum G; Zohar Y; Anunu R; Klapper L; Elkeles A; Seagal J; Yefenof E; Ayalon-Soffer M; Karin N
J Immunol; 2009 Jul; 183(1):732-9. PubMed ID: 19535619
[TBL] [Abstract][Full Text] [Related]
15. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
16. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
Alcamí A; Symons JA; Collins PD; Williams TJ; Smith GL
J Immunol; 1998 Jan; 160(2):624-33. PubMed ID: 9551896
[TBL] [Abstract][Full Text] [Related]
17. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch.
Benarafa C; Collins ME; Hamblin AS; Cunningham FM
Vet Rec; 2002 Dec; 151(23):691-3. PubMed ID: 12503787
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions.
Gavrilin MA; Gulina IV; Kawano T; Dragan S; Chakravarti L; Kolattukudy PE
Biochem Biophys Res Commun; 2005 Feb; 327(2):533-40. PubMed ID: 15629146
[TBL] [Abstract][Full Text] [Related]
20. The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion.
Furlan F; Orlando S; Laudanna C; Resnati M; Basso V; Blasi F; Mondino A
J Cell Sci; 2004 Jun; 117(Pt 14):2909-16. PubMed ID: 15173320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
